NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 237 filers reported holding NOVOCURE LTD in Q1 2024. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $25,951,950 | +9.6% | 1,515,000 | 0.0% | 11.32% | +23.0% |
| Q1 2024 | $23,679,450 | +4.7% | 1,515,000 | 0.0% | 9.20% | +54.2% |
| Q4 2023 | $22,618,950 | -7.6% | 1,515,000 | 0.0% | 5.97% | +23.1% |
| Q3 2023 | $24,467,250 | -61.1% | 1,515,000 | 0.0% | 4.85% | -55.0% |
| Q2 2023 | $62,872,500 | -31.0% | 1,515,000 | 0.0% | 10.78% | -27.4% |
| Q1 2023 | $91,112,100 | -18.0% | 1,515,000 | 0.0% | 14.85% | +7.1% |
| Q4 2022 | $111,125,249 | – | 1,515,000 | – | 13.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |